Microbot Medical Inc.
MBOT
$2.23
-$0.26-10.44%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -5.51% | -30.43% | -3.96% | 24.83% | -28.95% |
| Total Depreciation and Amortization | 13.04% | 64.29% | -50.00% | -20.00% | 75.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 0.71% | -15.11% | -26.93% | -81.55% | 822.93% |
| Change in Net Operating Assets | 815.79% | -6.75% | 130.75% | 54.19% | -329.11% |
| Cash from Operations | 38.71% | -40.98% | 19.13% | -32.89% | -10.03% |
| Capital Expenditure | -- | 100.00% | 71.43% | -380.00% | 117.86% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -200.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 972.86% | -88.24% | 193.70% | -142.99% | 216.03% |
| Cash from Investing | 967.86% | -88.20% | 192.37% | -143.42% | 214.97% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 347.39% | -69.48% | -13.48% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 347.39% | -69.48% | -13.48% | -- | 100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 232.73% | -252.42% | 199.69% | -215.05% | 125.89% |